ArticleCancer drug resistance (Alhambra, Calif.)2021

Albumin nanoformulations as an innovative solution to overcome doxorubicin chemoresistance.

Federica Bessone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.